These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10715426)

  • 1. Histopathologic findings of renal allografts surviving more than 10 years after transplantation.
    Yamaguchi Y; Tanabe K; Shimizu T; Matsugami K; Fuchinoue S; Toma H; Agishi T
    Transplant Proc; 2000 Mar; 32(2):308-10. PubMed ID: 10715426
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapamycin in a porcine renal transplant model.
    Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospective randomised study of the influence of cyclosporin on long-term renal allograft function.
    Rowe PA; Watson MA; McMillan MA; Briggs JD; Rodger RS; Junor BJ
    Transplant Proc; 1994 Oct; 26(5):2617-8. PubMed ID: 7940814
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of subclinical rejection on renal allograft histology and function at 6 months.
    Rush D; Jeffery J; Trpkov K; Solez K; Gough J
    Transplant Proc; 1996 Feb; 28(1):494-5. PubMed ID: 8644325
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic renal allograft function under cyclosporin treatment. Leuven Collaborative Group for Transplantation.
    Vanrenterghem Y; Peeters J
    Transplant Proc; 1996 Aug; 28(4):2097-9. PubMed ID: 8769165
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil prevents the progression of chronic kidney allograft nephropathy.
    Park JH; Park JH; Yang CW; Kim YS; Kim SY; Moon IS; Koh YB; Bang BK
    Transplant Proc; 2000 Nov; 32(7):1747. PubMed ID: 11119917
    [No Abstract]   [Full Text] [Related]  

  • 8. Histopathologic findings in routine biopsies of renal transplant allografts.
    Toki K; Kyo M; Takahara S; Hatori M; Morozumi K; Ichimaru N; Wang JD; Ding XQ; Miyamoto M; Oka K; Kyakuno M; Kojima Y; Kokado Y; Okuyama A
    Transplant Proc; 1999 Sep; 31(6):2655-8. PubMed ID: 10500759
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation: results at 7 years.
    Tarantino A; Segoloni GP; Cambi V; Rizzo G; Altieri P; Mastrangelo F; Castagneto M; Salvadori M; Valente U; Cossu M; Federico S; Pisani F; Montagnino G; Messina M; Arisi L; Carmellini M; Piredda GB; Ponticelli C
    Transplant Proc; 1998 Aug; 30(5):1729-31. PubMed ID: 9723258
    [No Abstract]   [Full Text] [Related]  

  • 10. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage.
    Sumethkul V; Jirasiritham S; Chiewsilp P
    Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycophenolate mofetil conversion or addition in patients with chronic progressive deterioration of renal allograft function.
    Altaca G; Berber I; Aydin C; Yigit B; Aydin M; Titiz I
    Transplant Proc; 2001; 33(7-8):3248-9. PubMed ID: 11750391
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term follow-up (5 and 10 years) in recipients of HLA identical living related donor kidney grafts receiving continuous cyclosporine compared with azathioprine.
    MacDonald AS; Belitsky P; Bitter-Suermann H; Lawen J; MacSween M; Kiberd B; West K; McAlister VC
    Transplant Proc; 1997; 29(1-2):190. PubMed ID: 9122958
    [No Abstract]   [Full Text] [Related]  

  • 13. Trial of steroid withdrawal in renal transplant recipients with long-term--surviving allograft.
    Mizuno Y; Kikuchi H; Fujimori K; Doi H; Orii T; Ohkohchi N; Satomi S
    Transplant Proc; 2000 Nov; 32(7):1677-8. PubMed ID: 11119888
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone.
    Fabrega AJ; Roy G; Reynolds L; Corwin C; Hunsicker L
    Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term improvement of chronic renal graft dysfunction in cyclosporine-treated patients by addition of azathioprine and reduction of cyclosporine.
    Kliem V; Repp H; Frei U
    Transplant Proc; 1994 Oct; 26(5):2553-5. PubMed ID: 7940788
    [No Abstract]   [Full Text] [Related]  

  • 16. Conversion from cyclosporine to azathioprine at 3 months after renal transplantation: long-term results.
    van Wezel HB; Hilbrands LB; Koene RA; Hoitsma AJ
    Transplant Proc; 1994 Oct; 26(5):2550-2. PubMed ID: 7940787
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of immunosuppressive therapy on graft half-life projections. The Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1999 Nov; 31(7A):31S-33S. PubMed ID: 10576040
    [No Abstract]   [Full Text] [Related]  

  • 18. Early fluctuation in cyclosporine A trough levels affects long-term outcome of kidney transplants.
    Inoue S; Beck Y; Nagao T; Uchida H
    Transplant Proc; 1994 Oct; 26(5):2571-3. PubMed ID: 7940795
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic allograft nephropathy: a prospective randomised trial of cyclosporin reduction with or without mycophenolate mofetil.
    Jain S; Metcalfe M; White SA; Furness PN; Nicholson ML
    Transplant Proc; 2001 May; 33(3):2165-6. PubMed ID: 11377488
    [No Abstract]   [Full Text] [Related]  

  • 20. Results of renal transplantation over 20 years after surgery, using azathioprine and low-dose prednisolone as the sole immunosuppression.
    Yoshimura N; Okamoto M; Akioka K; Nakamura K; Ushigome H; Kadotani Y; Nobori S; Higuchi A; Ohmori Y
    Transplant Proc; 2003 Feb; 35(1):143-4. PubMed ID: 12591340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.